Skip to content

Drug interactions

Berotralstat + Imatinib

Severity: Moderate

Berotralstat and Imatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Berotralstat is a substrate of P-gp and BCRP, and it inhibits P-gp, BCRP and CYP enzymes. Each drug may raise the other's exposure modestly, with possible increases in gastrointestinal effects or QT effects of berotralstat.

What this interaction means in plain words

Berotralstat and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Berotralstat belongs to Miscellaneous; Imatinib belongs to Oncology.

Evidence level: Low

Why it happens

Imatinib inhibits BCRP and P-gp, raising berotralstat exposure, while berotralstat inhibits P-gp and raises imatinib exposure.

What to do

Monitor for adverse effects of both drugs, including gastrointestinal symptoms and QT prolongation.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Berotralstat and Imatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Berotralstat with Imatinib?

MediHelp rates the interaction as moderate. Berotralstat and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Berotralstat is a substrate of P-gp and BCRP, and it inhibits P-gp, BCRP and CYP enzymes. Each drug may raise the other's exposure modestly, with possible increases in gastrointestinal effects or QT effects of berotralstat.

How serious is the interaction between Berotralstat and Imatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for adverse effects of both drugs, including gastrointestinal symptoms and QT prolongation.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in